Renal Flashcards
Describe the 3 zones of the adrenals and what hormones they produce
Adrenal cortex (mnemonic GFR - ACD)
• Zona Glomerulosa (on outside): mineralocorticoids, mainly Aldosterone
• Zona Fasciculata (middle): glucocorticoids, mainly Cortisol
• Zona Reticularis (on inside): androgens, mainly Dehydroepiandrosterone (DHEA)
Describe the renin - angiotensin - aldosterone system
-Where is renin released from and why
-what does this do
-what happens to angiotensin and where does this take place
-what does this result in
-where is aldosterone released from and why
-what does this cause
Renin
• Released by JGA cells in kidney in response to ↓ renal perfusion, low sodium
• Hydrolyses angiotensinogen to form angiotensin I
Angiotensin
• ACE in lung converts angiotensin I → angiotensin II
• Vasoconstriction leads to raised BP
• Stimulates thirst
• Stimulates aldosterone and ADH release
Aldosterone
• Released by the zona glomerulosa in response to raised angiotensin II, potassium, and ACTH levels
• Causes retention of Na+ in exchange for K+/H+ in distal tubule
what factors stimulate renin secretion?
Factors stimulating renin secretion
• ↓ BP → ↓ renal prefusion
• Hyponatremia
• Sympathetic nerve stimulation
• Catecholamines
• Erect posture
what factors reduce renin secretion?
Factors reducing renin secretion
• β-blockers
• NSAIDS
what urinalysis is shown:
• Few RBCs (of normal morphology)
• Fine grandular cast or hyaline cast
or
-Dysmorphic RBCs
or
-WBCs+whitecellcast
or
• Red cell casts
Normal
• Few RBCs (of normal morphology)
• Fine grandular cast or hyaline cast
Glomerular Disease
-Dysmorphic RBCs
UTI and Pylonephritis
-WBCs+whitecellcast
Glomerulonephritis
• Red cell casts
what happens to:
Vit D
Phosphate
Calcium
Parathyroid hormone
in kidney disease
• Low vitamin D (1-α hydroxylation normally occurs in the kidneys)
• High phosphate due to ↓ execretion.
• Low calcium: due to lack of vitamin D,
high phosphate
• Secondary hyperparathyroidism: due to
low calcium, high phosphate and low vitamin D
What clinical manifestation may result from:
-hyperparathyroidism in kidney disease
Osteitis fibrosa cystica
o AKA hyperparathyroid bone disease
• Adynamic bone disease
o Reduction in cellular activity (both osteoblasts
and osteoclasts) in bone
oMay be due to over treatment with vitamin D
• Osteomalacia
o Due to low vitamin D
• Osteosclerosis
• Osteoporosis
describe the management of anaemia in CKD
-what level should ferritin be before starting EPO?
-what is the Hb target
-why should the Hb not be too high
-why should the Hb not be too low
Management:
• Correction o iron with IV if needed
• Ferritin should be > 200 ng/mL before starting EPO
• EPO is used to target Hb 10-12 (>11 or hematocrit >33%) reach the target within 4 months
• Corrected Hb of > 13.5 is associate with HTN crisis
• Hb < 10.5 ↑ risk of seizures.
what is EPO
-what does it do?
-what are it’s main uses?
Erythropoietin: (EPO) is a hematopoietic growth factor that stimulates the production of erythrocytes. The main uses of erythropoietin are to treat the anemia associated with chronic renal failure and that associated with cytotoxic therapy
what are the 8 side effects assoc with EPO
• HTN and HTN crisis, potentially → encephalopathy and seizures (BP ↑ in 25% of patients)
• EPO induced seizures occurs after 90 days from starting the treatment
• Bone aches
• Flu-like symptoms
• Skin rashes, urticaria
• Pure red cell aplasia* (due to antibodies against erythropoietin)
(*the risk is greatly ↓ with darbepoetin)
• Raised packed cell volume (PCV) =HCT → ↑ risk of thrombosis (e.g. Fistula)
• Iron deficiency 2nd to ↑ erythropoiesis
why may patients fail to respond with EPO?
• Iron deficiency
• Inadequate dose
• Concurrent infection/inflammation
• Hyperparathyroid bone disease
• Aluminum toxicity
how long can EPO be detected in urine until?
EPO can be detected in urine for few weeks after the latest dose
what are 5 indications for urgent dialysis?
• Severe acidosis
• Pulmonary edema due to volume overload
• Hyperkalemia
• Uremic pericarditis
• Severe uremic symptoms: Encephalopathy/Vomiting
what is hyperacute graft rejection due to in renal transplantation?
-what antibody mediates this?
-is this common?
Hyperacute graft rejection is due to pre-existent antibodies to HLA antigens and is therefore IgG
mediated
• Due to antibodies against donor HLA type 1 antigens
• Rarely seen due to HLA matching
describe the 1 and 10 year survival rate for cadaveric transplants vs living-donar transplants
Graft survival
• 1 year = 90%, 10 years = 60% for cadaveric transplants
• 1 year = 95%, 10 years = 70% for living-donor transplants
what are 6 post-op problems up to 4 months post-op in renal transplant?
Post-op problems (can cause graft dysfunction) – up to 4 months post-op:
• Acute rejection: risk is great in 1st 2 weeks occurs in 30-50% of cases
• Ciclosporin toxicity
• ATN of graft
• Vascular thrombosis
• Urine leakage
• UTI
describe the management of acute graft failure <6mths
Management of acute graft failure (< 6 months)
• Acute rejection: give steroids, if resistant use monoclonal antibodies
what are 3 causes of chronic graft failure i.e. >6mths?
Causes of chronic graft failure (> 6 months)
• Chronic allograft nephropathy
• Ureteric obstruction
• Recurrence of original renal disease (Mesangiocapillary glomerulonephritis > IgA > Focal segmental glomerulosclerosis)
Autosomal dominant polycystic kidney disease:
-what 2 disease loci have been identified and what do these code for?
Autosomal Dominant Polycystic Kidney Disease: (ADPKD) is the most common inherited cause of kidney disease, affecting 1 in 1,000 Caucasians. Two disease loci have been identified, PKD1 and PKD2, which code for polycystin-1 and polycystin-2 respectively
Autosomal dominant polycystic kidney disease type 1:
-what percentage of cases
-which chromosome
-how does this present?
85% cases
chromosome 16
presents with renal failure early
Autosomal dominant polycystic kidney disease type 2:
-what percentage of cases
-which chromosome
15%
chromosome 4
what is the diagnosis of ADPKD?
• In < 20 yrs age, CT scan is not needed
• In < 20 yrs age, ultrasound gives false –ve
• 2 cysts, unilateral or bilateral, if aged < 30 years
• 2 cysts in both kidneys if aged 30-59 years
• 4 cysts in both kidneys if aged > 60 years
what are assoc. conditions with ADPKD:
Associated conditions:
• Colonic diverticula (with any related symptoms, screen by barium enema)
• Mitral Valve Prolapse (needs echo screening)
• Berry aneurysms
what is the management of adult polycystic kidney disease?
Management:
• Painkillers
• Urinary tract infections: → ABX
• ↑BP control
• End-stage renal disease → Transplantation
For select patients, tolvaptan (vasopressin receptor 2 antagonist) may be an option. NICE recommended it as an option for treating ADPKD in adults to slow the progression of cyst development and renal insufficiency only if:
they have chronic kidney disease stage 2 or 3 at the start of treatment
there is evidence of rapidly progressing disease and
the company provides it with the discount agreed in the patient access scheme